These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 783228

  • 1. Management of a lacerated frenum and lip in a child with severe hemophilia and an inhibitor: report of case.
    Powell D.
    ASDC J Dent Child; 1976; 43(4):272-5. PubMed ID: 783228
    [No Abstract] [Full Text] [Related]

  • 2. [Dental treatment of a hemophilic patient].
    Olivier M.
    J Dent Que; 1981 Feb; 18():55-8. PubMed ID: 6785330
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. T lymphocyte proliferative responses induced by recombinant factor VIII in hemophilia A patients with inhibitors.
    Singer ST, Addiego JE, Reason DC, Lucas AH.
    Thromb Haemost; 1996 Jul; 76(1):17-22. PubMed ID: 8819245
    [Abstract] [Full Text] [Related]

  • 6. [Anti-factor VIII antibodies in children with hemophilia, and the management of hemorrhage].
    Klukowska A, Adamowicz-Salach A, Kamińska D, Zieleniewska B.
    Pol Tyg Lek; 1987 Jul 27; 42(30):911-4. PubMed ID: 3118341
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Incidence of the appearance of factor VIII inhibitor in patients with hemophilia A at the Hemophilia Center of the Clinical Hospital Center in Zagreb].
    Ficović P, Tiefenbach A, Brkljacić V, Grgić Z.
    Lijec Vjesn; 1983 Oct 27; 105(10):410-1. PubMed ID: 6418997
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T, Skopál J, Csáki C, Laczkó M, Schuler D, Borsi J.
    Orv Hetil; 1993 Dec 26; 134(52):2873-5. PubMed ID: 8272354
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of factor VIII inhibitors in patients with hemophilia A in Brazil.
    Rieger A, Roisenberg I.
    Thromb Haemost; 1999 Mar 26; 81(3):475-6. PubMed ID: 10102489
    [No Abstract] [Full Text] [Related]

  • 18. Reactivation of chronic hepatitis C virus infection by immunoadsorption in factor VIII inhibitor haemophilia.
    Rommel F, Toepfer M, Eberle J, Schiffl H, Spannagl M, Schramm W.
    Thromb Haemost; 2000 Oct 26; 84(4):733-4. PubMed ID: 11057884
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Combined plasmapheresis and immunosuppression in hemophilia in a patient with antibodies].
    Révész T, Mátyus J, Goldschmidt B, Harsányi V.
    Orv Hetil; 1980 Jul 20; 121(29):1753-4. PubMed ID: 6779250
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.